Novo Nordisk A/S | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Bausch Health Companies USD -1174000000 947M 2024-09
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
GlaxoSmithKline GBP 13.67B 218M 2024-12
Merck USD 46.31B 1.81B 2024-12
Novartis USD 44.05B 605M 2024-12
Novo Nordisk 120.52B 8B 2024-09
Novo Nordisk DKK 120.52B 8B 2024-09
Pacira USD 778.35M 28.76M 2024-12
Sanofi 73B 1.36B 2024-06
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12



Novo Nordisk A/S Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.